Risk of Severe Coronavirus Disease 2019 in Patients With Inflammatory Bowel Disease in the United States: A Multicenter Research Network StudyMulticenter Study Published on 2020-10-012023-07-06 Journal: Gastroenterology [Category] SARS, [키워드] COVID-19 Crohn’s disease IBD Inflammatory bowel disease ulcerative colitis [DOI] 10.1053/j.gastro.2020.06.003 PMC 바로가기 [Article Type] Multicenter Study
IBD Patients Could Be Silent Carriers for Novel Coronavirus and Less Prone to its Severe Adverse Events: True or False?Short Communication Published on 2020-09-082022-10-31 Journal: Cell Journal (Yakhteh) [Category] COVID-19, [키워드] Adverse anti-inflammatory drug Anti-TNF-α anti-TNF-α bowel carrier Chronic disorder Complication coronavirus Corticosteroids COVID-19 Crohn’s disease disease gastrointestinal tract healthy higher risk IBD Immunosuppressant induce Infectious disease Inflammation Mild moderate novel pandemic Patient prone receive reduce silent Treatment ulcerative colitis virus [DOI] 10.22074/cellj.2020.7603 PMC 바로가기 [Article Type] Short Communication
The Course of SARS-COV2 Infection Was Not Severe in a Crohn’s Patient Who Administered Maintenance Anti-TNF Therapy Overlapping the Early Pre-Symptomatic Period of InfectionCase Report Published on 2020-08-152022-10-27 Journal: Antibodies [Category] COVID-19, [키워드] Activation addition anti-cytokine therapy anti-Tumor Necrosis Factor (TNF) adalimumab Course COVID-19 COVID-19 infection digestive early infection Evidence fecal calprotectin IBD immune response immunosuppressive medications Infection inflammatory bowel disease (IBD) inhibit maintenance medication Patient Period pre-symptomatic risk symptoms of COVID-19 the cytokine storm Treatment virus [DOI] 10.3390/antib9030042 PMC 바로가기 [Article Type] Case Report
COVID-19 and Inflammatory Bowel Disease: Patient Knowledge and Perceptions in a Single Center SurveyArticle Published on 2020-08-132022-10-30 Journal: Medicina [Category] COVID-19, MERS, [키워드] 95% CI 95% confidence interval Active disease Administered affected age Anxiety center China Clinical characteristics country COVID-19 Crohn disease disease evaluate FIVE Health care IBD increasing age individual Inflammatory bowel disease knowledge male management material measure Measures Most patient Odds ratio Older age pandemic Patient patients Perception Prevalence Prevention measures promote questionnaire reported Result SARS-COV-2 infection spreading survey These data variable [DOI] 10.3390/medicina56080407 PMC 바로가기 [Article Type] Article
Effectiveness and safety of vedolizumab in biologically naïve patients: A real-world multi-centre studyOriginal Article Published on 2020-08-092024-09-04 Journal: United European gastroenterology journal [Category] 대상포진, [키워드] Crohn’s disease IBD Inflammatory bowel disease ulcerative colitis vedolizumab [DOI] 10.1177/2050640620948802 PMC 바로가기 [Article Type] Original Article
Can medicinal mushrooms have prophylactic or therapeutic effect against COVID‐19 and its pneumonic superinfection and complicating inflammation?Review Published on 2020-07-292022-10-29 Journal: Scandinavian journal of immunology [Category] Coronavirus, MERS, SARS, [키워드] active against Agaricus Bacteria Can complicate COVID‐19 COVID‐19 infection COVID‐19 infection different diseases Effect Grifola frondosa Hericium erinaceus IBD immunomodulatory IMPROVE in vitro in vivo Infection Inflammation inflammatory disorders mechanism medicinal mushrooms mice microbe parasite Patient pneumococcal pneumococcal infection Prophylactic Quality of life reduce Sepsis severe lung inflammation shown significantly survival Symptom therapeutic effect Treatment [DOI] 10.1111/sji.12937 PMC 바로가기 [Article Type] Review
Immunological co-ordination between gut and lungs in SARS-CoV-2 infectionArticle Published on 2020-07-242022-11-01 Journal: Virus research [Category] COVID-19, SARS, [키워드] ACE2 ACE2 receptor acute respiratory syndrome Affect alveolar Amino acid Cell ciliated cell coronavirus coronavirus disease COVID-19 COVID-19 infection COVID-19 patient COVID-19 patients detected in stool Diagnosis Enterocyte enzyme epithelial expressed facilitate Fecal sample gastrointestinal tract GI Tract Gut gut microbial ecology gut–lung axis Health human-to-human transmission hygiene IBD immunological infect Inflammatory bowel disease lung Lungs microbiota organ pandemic patients receptor RNA SARS-CoV-2 SARS-COV-2 infection subsequent Symptom transmission of SARS-CoV-2 Transport Viral RNA [DOI] 10.1016/j.virusres.2020.198103 PMC 바로가기 [Article Type] Article
Questionnaire assessment helps the self-management of patients with inflammatory bowel disease during the outbreak of Coronavirus Disease 2019Research Paper Published on 2020-07-152022-10-28 Journal: Aging (Albany NY) [Category] COVID-19, SARS, [키워드] condition COVID-19 diagnosis of COVID-19 disease doctor eligible Epidemic epidemic of COVID-19 epidemiological feature good quality help IBD index Inflammatory bowel disease medication outbreak Part Patient physical question questionnaire reduction in regimen reported risk factor score Self-management the disease the epidemic the patient ulcerative colitis worsening [DOI] 10.18632/aging.103525 PMC 바로가기 [Article Type] Research Paper
COVID-19 and Inflammatory Bowel Diseases: Risk Assessment, Shared Molecular Pathways, and Therapeutic ChallengesReview Article Published on 2020-07-102022-10-31 Journal: Gastroenterology Research and Practice [Category] COVID-19, [키워드] “cytokine storm” angiotensin-converting enzyme 2 article assessment CD209L challenge Coronavirus infection COVID-19 COVID-19 disease database disease Effect eukaryotic translation explain General population higher risk IBD immunopathology Immunosuppressive medication increased risk Infection infectious risk Inflammatory bowel disease inflammatory bowel diseases Interaction interferon signaling knowledge management medication MERS-CoV molecular Neural novel coronavirus SARS-CoV-2 outbreak outcome outcomes Pathogenesis pathogenic coronavirus pathway Patient Patient care phosphorylated Protective public health receptors SARS-CoV-1 SARS-CoV-2 SARS-COV-2 infection second subunit Support susceptibility therapeutic threat Treatment treatment strategy viral endocytosis was used yielding [DOI] 10.1155/2020/1918035 PMC 바로가기 [Article Type] Review Article
Outcomes of COVID-19 in 79 patients with IBD in Italy: an IG-IBD studyObservational Study Published on 2020-07-012023-06-19 Journal: Gut [Category] Fulltext, SARS, [키워드] Epidemiology IBD [DOI] 10.1136/gutjnl-2020-321411 PMC 바로가기 [Article Type] Observational Study